Pravastatin Sodium Tablet
Product Images NDC 71610-877

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Pravastatin Sodium (NDC 71610-877). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (71610 0877 30)

PRAVASTATIN SODIUM 80 mg oral tablet carton label showing 30 tablets per package. The label includes storage instructions to store between 20-25 degrees Celsius and to use a USP controlled room temperature compliant container. It identifies the labeler as Aphena Pharma Solutions - Tennessee, LLC, located in Cookeville, TN, and includes the product NDC 71610-877-30.*

FDA Label Image

Aphena (Aphena)

FDA Label Image

Chem Structure (Chemstructure)

Chemical structure diagram of pravastatin sodium, showing its molecular arrangement and bonds as typically depicted in pharmaceutical labeling for this active ingredient.*

FDA Label Image

Graph (Figure1)

A survival distribution plot comparing the proportion of subjects without coronary heart disease death or nonfatal myocardial infarction over time in years since randomization. The graph shows separate curves for placebo and pravastatin groups, with a logrank P value of 0.0001 indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.